Back to mobile site

Edwards Lifesciences (EW) PT Raised to $182 at RBC Capital

February 1, 2019 6:42 AM EST Send to a Friend
RBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login